ID   HNRPQ_RAT               Reviewed;         533 AA.
AC   Q7TP47;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   24-JUL-2024, entry version 145.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein Q;
DE            Short=hnRNP Q;
DE   AltName: Full=Liver regeneration-related protein LRRG077;
DE   AltName: Full=Synaptotagmin-binding, cytoplasmic RNA-interacting protein;
GN   Name=Syncrip; Synonyms=Hnrpq; ORFNames=Ab2-339;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Xu C.S., Li W.Q., Li Y.C., Ma H., Wang L., Wang S.F., Han H.P., Wang G.P.,
RA   Chai L.Q., Yuan J.Y., Yang K.J., Yan H.M., Chang C.F., Zhao L.F., Shi J.B.,
RA   Rahman S., Wang Q.N., Zhang J.B.;
RT   "Liver regeneration after PH.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in
CC       mRNA processing mechanisms. Component of the CRD-mediated complex that
CC       promotes MYC mRNA stability. Is associated in vitro with pre-mRNA,
CC       splicing intermediates and mature mRNA protein complexes. Binds to apoB
CC       mRNA AU-rich sequences. Part of the APOB mRNA editosome complex and may
CC       modulate the postranscriptional C to U RNA-editing of the APOB mRNA
CC       through either by binding to A1CF (APOBEC1 complementation factor), to
CC       APOBEC1 or to RNA itself. May be involved in translationally coupled
CC       mRNA turnover. Implicated with other RNA-binding proteins in the
CC       cytoplasmic deadenylation/translational and decay interplay of the FOS
CC       mRNA mediated by the major coding-region determinant of instability
CC       (mCRD) domain. Interacts in vitro preferentially with poly(A) and
CC       poly(U) RNA sequences. May be involved in cytoplasmic vesicle-based
CC       mRNA transport through interaction with synaptotagmins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Identified in a histone pre-mRNA complex, at least composed of
CC       ERI1, LSM11, SLBP, SNRPB, SYNCRIP and YBX1. Identified in the
CC       spliceosome C complex (By similarity). Component of the coding region
CC       determinant (CRD)-mediated complex, composed of DHX9, HNRNPU, IGF2BP1,
CC       SYNCRIP and YBX1. Identified in a mRNP complex, at least composed of
CC       DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2,
CC       STAU1, STAU2, SYNCRIP and YBX1. Identified in a mRNP granule complex,
CC       at least composed of ACTB, ACTN4, DHX9, ERG, HNRNPA1, HNRNPA2B1,
CC       HNRNPAB, HNRNPD, HNRNPL, HNRNPR, HNRNPU, HSPA1, HSPA8, IGF2BP1, ILF2,
CC       ILF3, NCBP1, NCL, PABPC1, PABPC4, PABPN1, RPLP0, RPS3, RPS3A, RPS4X,
CC       RPS8, RPS9, SYNCRIP, YBX1 and untranslated mRNAs. Component of the APOB
CC       mRNA editosome. Interacts with APOBEC1 and A1CF. Part of a complex
CC       associated with the FOS mCRD domain and consisting of PABPC1, PAIP1,
CC       CSDE1/UNR, HNRPD and SYNCRIP. Interacts with HNRPR, SMN, POLR2A
CC       hyperphosphorylated C-terminal domain, minute virus of mice (MVM) NS1
CC       protein and through its C-terminal domain with SYT7, SYT8 and SYT9. The
CC       non-phosphorylated and phosphorylated forms are colocalized with PAIP1
CC       in polysomes. Interacts with GTPBP1 (By similarity). Interacts with
CC       HABP4 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:O43390}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O43390}. Nucleus {ECO:0000250|UniProtKB:Q7TMK9}.
CC       Microsome {ECO:0000250|UniProtKB:Q7TMK9}. Note=Localized in cytoplasmic
CC       mRNP granules containing untranslated mRNAs (By similarity). Expressed
CC       predominantly in the nucleoplasm. The tyrosine phosphorylated form
CC       bound to RNA is found in microsomes (By similarity).
CC       {ECO:0000250|UniProtKB:O43390, ECO:0000250|UniProtKB:Q7TMK9}.
CC   -!- DOMAIN: The domain containing eight Arg-Gly-Gly repeats (RGG/RXR-box)
CC       may be involved in RNA-binding and protein-protein interactions. It is
CC       methylated by PRMT1, and essential for nuclear localization (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine. The membrane-bound form found in
CC       microsomes is phosphorylated in vitro by insulin receptor tyrosine
CC       kinase (INSR). Phosphorylation is inhibited upon binding to RNA,
CC       whereas the cytoplasmic form is poorly phosphorylated.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY325202; AAP92603.1; -; mRNA.
DR   RefSeq; NP_001041381.1; NM_001047916.2.
DR   AlphaFoldDB; Q7TP47; -.
DR   SMR; Q7TP47; -.
DR   BioGRID; 263972; 4.
DR   IntAct; Q7TP47; 3.
DR   MINT; Q7TP47; -.
DR   STRING; 10116.ENSRNOP00000065252; -.
DR   GlyGen; Q7TP47; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q7TP47; -.
DR   PhosphoSitePlus; Q7TP47; -.
DR   jPOST; Q7TP47; -.
DR   PaxDb; 10116-ENSRNOP00000048433; -.
DR   Ensembl; ENSRNOT00000041655.5; ENSRNOP00000048433.4; ENSRNOG00000000204.8.
DR   Ensembl; ENSRNOT00055029508; ENSRNOP00055023698; ENSRNOG00055017437.
DR   Ensembl; ENSRNOT00060021000; ENSRNOP00060016572; ENSRNOG00060012376.
DR   Ensembl; ENSRNOT00065020561; ENSRNOP00065015814; ENSRNOG00065012619.
DR   GeneID; 363113; -.
DR   KEGG; rno:363113; -.
DR   UCSC; RGD:1305683; rat.
DR   AGR; RGD:1305683; -.
DR   CTD; 10492; -.
DR   RGD; 1305683; Syncrip.
DR   eggNOG; KOG0117; Eukaryota.
DR   GeneTree; ENSGT00940000153511; -.
DR   InParanoid; Q7TP47; -.
DR   OMA; GNMASEH; -.
DR   OrthoDB; 3184171at2759; -.
DR   PRO; PR:Q7TP47; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000000204; Expressed in thymus and 18 other cell types or tissues.
DR   ExpressionAtlas; Q7TP47; baseline and differential.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0070937; C:CRD-mediated mRNA stability complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0097452; C:GAIT complex; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0071204; C:histone pre-mRNA 3'end processing complex; ISS:UniProtKB.
DR   GO; GO:0106002; C:mCRD-mediated mRNA stability complex; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:1990635; C:proximal dendrite; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:RGD.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:RGD.
DR   GO; GO:0008143; F:poly(A) binding; ISO:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; ISO:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0070934; P:CRD-mediated mRNA stabilization; ISO:RGD.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0090367; P:negative regulation of mRNA modification; IMP:RGD.
DR   GO; GO:1900152; P:negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISO:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISO:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd12483; RRM1_hnRNPQ; 1.
DR   CDD; cd12489; RRM2_hnRNPQ; 1.
DR   CDD; cd12495; RRM3_hnRNPQ; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR034544; hnRNPQ_RRM1.
DR   InterPro; IPR034548; hnRNPQ_RRM2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   NCBIfam; TIGR01648; hnRNP-R-Q; 1.
DR   PANTHER; PTHR21245; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; 1.
DR   PANTHER; PTHR21245:SF11; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 3.
DR   PROSITE; PS50102; RRM; 3.
PE   2: Evidence at transcript level;
KW   Acetylation; Cytoplasm; Endoplasmic reticulum; Isopeptide bond;
KW   Methylation; Microsome; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Ribonucleoprotein; RNA-binding;
KW   Spliceosome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   CHAIN           2..533
FT                   /note="Heterogeneous nuclear ribonucleoprotein Q"
FT                   /id="PRO_0000081869"
FT   DOMAIN          72..151
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          153..235
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          248..318
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REPEAT          358..360
FT                   /note="1-1"
FT   REPEAT          361..363
FT                   /note="1-2"
FT   REPEAT          370..374
FT                   /note="2-1"
FT   REPEAT          379..382
FT                   /note="2-2"
FT   REPEAT          388..390
FT                   /note="1-3"
FT   REPEAT          395..398
FT                   /note="2-3"
FT   REPEAT          408..410
FT                   /note="1-4"
FT   REPEAT          436..438
FT                   /note="1-5"
FT   REPEAT          449..451
FT                   /note="1-6"
FT   REPEAT          464..466
FT                   /note="1-7"
FT   REPEAT          467..469
FT                   /note="1-8"
FT   REGION          310..471
FT                   /note="Interaction with APOBEC1"
FT                   /evidence="ECO:0000250"
FT   REGION          358..469
FT                   /note="8 X 3 AA repeats of R-G-G"
FT   REGION          370..398
FT                   /note="3 X 4 AA repeats of Y-Y-G-Y"
FT   REGION          407..533
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          428..459
FT                   /note="Interaction with SMN"
FT                   /evidence="ECO:0000250"
FT   MOTIF           474..488
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        484..509
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..533
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         69
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         131
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         273
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         283
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         354
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         354
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         406
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         420
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         428
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         428
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         436
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         436
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         446
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         446
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         449
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         449
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   MOD_RES         497
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   CROSSLNK        78
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
FT   CROSSLNK        517
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O60506"
SQ   SEQUENCE   533 AA;  59710 MW;  EC218ECF4FC00FBF CRC64;
     MATEHVNGNG TEEPMDTTSA VIHSENFQTL LDAGLPQKVA EKLDEIYVAG QRKYGGPPPD
     SVYSGQQPSV GTEIFVGKIP RDLFEDELVP LFEKAGPIWD LRLMMDPLTG LNRGYAFVTF
     CTKEAAQEAV KLYNNHEIRS GKHIGVCISV ANNRLFVGSI PKSKTKEQIL EEFSKVTEGL
     TDVILYHQPD DKKKNRGFCF LEYEDHKTAA QARRRLMSGK VKVWGNVGTV EWADPIEDPD
     PEVMAKVKVL FVRNLANTVT EEILEKSFSQ FGKLERVKKL KDYAFIHFDE RDGAVKAMEE
     MNGKDLEGEN IEIVFAKPPD QKRKERKAQR QAAKNQMYDD YYYYGPPHMP PPTRGRGRGG
     RGGYGYPPDY YGYEDYYDYY GYDYHNYRGG YEDPYYGYED FQVGARGRGG RGARGAAPSR
     GRGAAPPRGR AGYSQRGGPG SARGVRGARG GAQQQRGRGV RGARGGRGGN VGGKRKADGY
     NQPDSKRRQT NNQNWGSQPI AQQPLQGGDH SGNYGYKSEN EEFYQDTFGQ QWK
//
